takanobu kato - Infectious Diseases

Author Information

Takanobu Kato is a distinguished researcher affiliated with the Department of Virology II at the National Institute of Infectious Diseases in Tokyo, Japan. His work is primarily focused on virology, with significant contributions to the understanding and treatment of various viral infections.

Research Contributions

Takanobu Kato has made substantial contributions to the field of infectious diseases, particularly in the study of hepatitis viruses. His research includes the exploration of mechanisms involved in viral entry and replication, the development of vaccines, and the identification of potential therapeutic agents. Notable works include studies on HBV/HDV entry mechanisms, induction of neutralizing antibodies against hepatitis C, and the analysis of drug resistance in hepatitis B virus. His work also extends to evaluating diagnostic tools and the emergence of specific hepatitis C virus genotypes among specific populations.

Aliases

The author is consistently referenced as Takanobu Kato in his publications.

Publication and Citation Metrics

Metric	Value
Total Citation Count	12,806
H-index	40
Total Paper Count	168

Publications:

The kinesin KIF4 mediates HBV/HDV entry through the regulation of surface NTCP localization and can be targeted by RXR agonists in vitro

DOI: 10.1371/journal.ppat.1009983

Year: 2022

Induction of neutralizing antibodies against hepatitis C virus by a subviral particle-based DNA vaccine.

DOI: 10.1016/j.antiviral.2022.105266

Year: 2022

Interferon-gamma induced APOBEC3B contributes to Merkel cell polyomavirus genome mutagenesis in Merkel cell carcinoma.

DOI: 10.1016/j.jid.2021.12.019

Year: 2021

Two cases of acute hepatitis with false positive for IgA HEV antibody

DOI: 10.2957/KANZO.62.64

Year: 2021

The kinesin KIF4 mediates HBV/HDV entry through regulation of surface NTCP localization and can be targeted by RXR agonists in vitro

DOI: 10.1101/2021.09.29.462331

Year: 2021

Inhibition of hepatitis C virus by vitamin D.

DOI: 10.1016/bs.vh.2021.06.006

Year: 2021

Biochemical and Structural Properties of Entecavir-Resistant Hepatitis B Virus Polymerase with L180M/M204V Mutations

DOI: 10.1128/JVI.02401-20

Year: 2021

Emergence of Hepatitis C Virus Genotype 2c Infection Among Human Immunodeficiency Virus–Infected Men Who Have Sex With Men in Tokyo, Japan

DOI: 10.1097/OLQ.0000000000001480

Year: 2021

Performance Evaluation of In Vitro Screening and Diagnostic Kits for Hepatitis C Virus Infection

DOI: 10.3389/fcimb.2021.793472

Year: 2021

Identification of natural compounds extracted from crude drugs as novel inhibitors of hepatitis C virus.

DOI: 10.1016/j.bbrc.2021.06.022

Year: 2021

What About Parasitic Pathogens?

What is the Future Outlook?

What are the recent advancements in RT-PCR?

What are Some Examples of Structural Proteins in Infectious Diseases?

What Role Does Vaccination Play in Global Health?

What Types of Surveillance Systems Exist?

How Can Zika Virus Be Prevented?

Are There Any Limitations to Wearing Masks?

What are the Symptoms of Viral Infections?

What is the Role of B Cells in Vaccination?

Partnered Content Networks

Relevant Topics